Minapharm Pharmaceuticals (MIPH) EPS

EPS

EGP 11.5884

Diluted EPS, fiscal year 2024

Earnings per share (EPS) is net income divided by the number of shares outstanding — the profit attributable to each share. Figures on this page are diluted EPS, in Egyptian pounds per share.

EPS history

Fiscal yearEPS (diluted)
202411.5884
2023-5.0062
202251.4136
202137.9395
202024.4668
201911.4769
20189.4686
201714.2666
20162.6806
20156.7494
20144.0135
20136.6054
20125.0152
20114.1465

Figures are diluted EPS, in EGP per share.

Key terms on this page

Earnings per Share (EPS)
Earnings per share is a company’s net profit attributable to shareholders divided by the weighted average number of outstanding shares. It expresses how much profit the company generated for each share during a period. EPS is the denominator of the P/E ratio and a core input in equity valuation.
Price-to-Earnings (P/E) Ratio
The price-to-earnings ratio divides a company’s share price by its earnings per share, showing how many pounds investors pay for each pound of annual profit. It is one of the most widely used valuation multiples for comparing listed companies within the same sector. A trailing P/E uses reported earnings, while a forward P/E uses forecast earnings.
Dividend Yield
Dividend yield is the annual cash dividend per share expressed as a percentage of the current share price. It measures the income a shareholder receives from distributions relative to the market price of the stock. Because the calculation uses the market price, the yield rises when the price falls and falls when the price rises, assuming the dividend is unchanged.

All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.